Australia markets close in 2 hours 10 minutes

Organogenesis Holdings Inc. (2PQ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.1800-0.0800 (-3.54%)
At close: 09:55PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 289.41M
Enterprise value 303.89M
Trailing P/E 58.40
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.72
Price/book (mrq)1.11
Enterprise value/revenue 0.70
Enterprise value/EBITDA 8.43

Trading information

Stock price history

Beta (5Y monthly) 1.57
52-week change 319.13%
S&P500 52-week change 323.57%
52-week high 34.2400
52-week low 31.7600
50-day moving average 32.6648
200-day moving average 32.7833

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5131.96M
Implied shares outstanding 6142.45M
Float 861.84M
% held by insiders 133.17%
% held by institutions 144.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 1.14%
Operating margin (ttm)0.65%

Management effectiveness

Return on assets (ttm)2.24%
Return on equity (ttm)1.82%

Income statement

Revenue (ttm)433.14M
Revenue per share (ttm)3.30
Quarterly revenue growth (yoy)-13.70%
Gross profit (ttm)N/A
EBITDA 31.69M
Net income avi to common (ttm)4.95M
Diluted EPS (ttm)0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)103.84M
Total cash per share (mrq)0.79
Total debt (mrq)121.68M
Total debt/equity (mrq)43.67%
Current ratio (mrq)2.80
Book value per share (mrq)2.12

Cash flow statement

Operating cash flow (ttm)30.92M
Levered free cash flow (ttm)18M